Twist Bioscience (TWST) Competitors $28.21 -0.26 (-0.91%) Closing price 03:59 PM EasternExtended Trading$28.61 +0.40 (+1.41%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TWST vs. ROIV, RVMD, BBIO, BPMC, ELAN, LEGN, TGTX, TLX, VRNA, and LNTHShould you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Roivant Sciences (ROIV), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Elanco Animal Health (ELAN), Legend Biotech (LEGN), TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Verona Pharma (VRNA), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry. Twist Bioscience vs. Roivant Sciences Revolution Medicines BridgeBio Pharma Blueprint Medicines Elanco Animal Health Legend Biotech TG Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Verona Pharma Lantheus Twist Bioscience (NASDAQ:TWST) and Roivant Sciences (NASDAQ:ROIV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Does the MarketBeat Community prefer TWST or ROIV? Twist Bioscience received 53 more outperform votes than Roivant Sciences when rated by MarketBeat users. However, 78.57% of users gave Roivant Sciences an outperform vote while only 59.34% of users gave Twist Bioscience an outperform vote. CompanyUnderperformOutperformTwist BioscienceOutperform Votes10859.34% Underperform Votes7440.66% Roivant SciencesOutperform Votes5578.57% Underperform Votes1521.43% Does the media refer more to TWST or ROIV? In the previous week, Roivant Sciences had 8 more articles in the media than Twist Bioscience. MarketBeat recorded 15 mentions for Roivant Sciences and 7 mentions for Twist Bioscience. Roivant Sciences' average media sentiment score of 1.47 beat Twist Bioscience's score of 1.39 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 13 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend TWST or ROIV? Twist Bioscience currently has a consensus price target of $50.40, indicating a potential upside of 76.51%. Roivant Sciences has a consensus price target of $17.50, indicating a potential upside of 60.18%. Given Twist Bioscience's higher probable upside, analysts plainly believe Twist Bioscience is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in TWST or ROIV? 64.8% of Roivant Sciences shares are owned by institutional investors. 3.0% of Twist Bioscience shares are owned by insiders. Comparatively, 7.9% of Roivant Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, TWST or ROIV? Twist Bioscience has a beta of 2.54, indicating that its share price is 154% more volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Is TWST or ROIV more profitable? Twist Bioscience has a net margin of -59.76% compared to Roivant Sciences' net margin of -119.54%. Roivant Sciences' return on equity of -14.05% beat Twist Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-59.76% -32.69% -25.25% Roivant Sciences -119.54%-14.05%-12.81% Which has preferable earnings and valuation, TWST or ROIV? Roivant Sciences has lower revenue, but higher earnings than Twist Bioscience. Roivant Sciences is trading at a lower price-to-earnings ratio than Twist Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$347.68M4.92-$208.73M-$3.25-8.79Roivant Sciences$122.59M63.59$4.35B-$0.15-72.83 SummaryRoivant Sciences beats Twist Bioscience on 12 of the 19 factors compared between the two stocks. Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TWST vs. The Competition Export to ExcelMetricTwist BioscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.71B$2.92B$5.35B$8.44BDividend YieldN/A1.68%5.21%4.11%P/E Ratio-8.4531.1926.9119.77Price / Sales4.92402.62390.06119.10Price / CashN/A168.6838.2534.62Price / Book3.743.236.794.52Net Income-$208.73M-$72.35M$3.23B$248.23M7 Day Performance-5.14%5.26%1.99%0.77%1 Month Performance-22.70%5.87%11.45%13.45%1 Year Performance-33.73%-26.71%17.35%7.67% Twist Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TWSTTwist Bioscience4.2923 of 5 stars$28.21-0.9%$50.40+78.7%-35.4%$1.69B$347.68M-8.35990Positive NewsROIVRoivant Sciences2.1443 of 5 stars$10.99+3.3%$17.50+59.2%-2.8%$7.84B$122.59M-73.26860Positive NewsUpcoming EarningsRVMDRevolution Medicines4.36 of 5 stars$41.88+3.6%$67.17+60.4%-2.3%$7.80B$742,000.00-11.67250Positive NewsBBIOBridgeBio Pharma4.5971 of 5 stars$35.68+4.4%$57.09+60.0%+12.2%$6.77B$127.42M-12.52400Positive NewsInsider TradeBPMCBlueprint Medicines1.7972 of 5 stars$100.31+3.2%$126.56+26.2%-2.0%$6.48B$562.12M-92.88640Positive NewsInsider TradeELANElanco Animal Health3.5038 of 5 stars$12.82+7.2%$15.00+17.0%-24.4%$6.36B$4.43B32.049,800Analyst ForecastGap UpLEGNLegend Biotech3.5343 of 5 stars$32.38+1.9%$78.82+143.4%-34.1%$5.95B$627.24M-34.081,070News CoverageAnalyst RevisionGap UpTGTXTG Therapeutics3.8137 of 5 stars$34.99+4.0%$40.80+16.6%+106.0%$5.56B$386.39M-349.87290Positive NewsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.25-5.4%$22.00+35.4%N/A$5.49B$783.21M0.00N/AGap DownVRNAVerona Pharma1.8312 of 5 stars$67.53+6.6%$81.50+20.7%+492.7%$5.48B$118.54M-35.1730Positive NewsGap DownLNTHLantheus4.4474 of 5 stars$79.52-2.7%$132.67+66.8%-6.9%$5.45B$1.54B13.23700Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Roivant Sciences Alternatives Revolution Medicines Alternatives BridgeBio Pharma Alternatives Blueprint Medicines Alternatives Elanco Animal Health Alternatives Legend Biotech Alternatives TG Therapeutics Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Verona Pharma Alternatives Lantheus Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TWST) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.